MITTEL ZUR LINDERUNG ODER HEILUNG VON CHRONISCHER PROSTATITIS, INTERSTITIELLER ZYSTITIS ODER BLASENENTLEERUNGSSTÖRUNGEN

Patent europeic · EP2545929 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2545929
Numer da la dumonda
EP11753428
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
10-03-2011
Publitgà
16-01-2013
Concedì
02-11-2016
Stritgà
23-10-2024
Motiv
Taxa annuala betg pajada
Classas IPC
A61P 13/08 (2006.01)
A61K 35/76 (2015.01)
Prioritad
JP 2010100234 23.04.2010
JP 2010054626 11.03.2010
Dumonda PCT
PCT/JP2011/055609 10.03.2011
Publicaziun PCT
WO2011/111770 15.09.2011
Lingua da l’annunzia
giapunais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-10-2024

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    23.10.2024
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 23.10.2024

  2. 01-04-2023

    Midada

    Published in Swissreg on 01.04.2023

  3. 02-11-2016

    Concedì

    Published in Swissreg on 02.11.2016

Partidas

Possessur

Nippon Zoki Pharmaceutical Co. Ltd

Nippon Zoki Pharmaceutical Co., Ltd.

1-2 Hiranomachi 2-chome Chuo-ku, Osaka-shi Osaka 541-0046, JP

Inventur

TAMAKI, Makoto

Aizuwakamatu-shi Fukushima 965-0866, JP

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.